PeptidePedia The community reference

Talk:List of GLP-1 receptor agonists

Discussion page·2 threads·no archives

This article is within the scope of the clinical evidence working group.

This is the discussion page for the article List of GLP-1 receptor agonists. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Excluding DPP-4 inhibitorsResolved

Excluding them is right — they are a different mechanism — but the exclusion should be stated rather than left for a reader to notice. — ListMakerLumi (talk) 09:50, 4 March 2026 (UTC)

Stated in the lead and again in the related-compounds section. ✓ Done — DPP4_Dagmar (talk) 13:25, 4 March 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Inclusion is not endorsementDone

A list of compounds reads as a menu unless it says otherwise. The lead now says inclusion is not endorsement and several entries are unapproved. — NPOV_Nadia (talk) 10:20, 24 June 2026 (UTC)

And the closing paragraph repeats it for the research-chemical case. ✓ Done — ListMakerLumi (talk) 13:55, 24 June 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 24 June 2026, by ListMakerLumi. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).